Netherlands

Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting blood vessels, today announces that it has secured nearly €50m of new financing, consisting of up to €37.5m from the EIB, supported under the European Commission’s InvestEU programme, and €10m from existing investors, including EQT, investing from its LSP Health Economics Fund 2, and Invest-NL. The proceeds raised will be used to advance aXess into commercialization, including upscaling production and hiring, and supporting the continued development of its broader pipeline. The EIB venture debt package consists of €10 million up front with optionality to further increase by an additional €27.5 million

Dutch-based Prodrive Technologies has signed a €40 million lending agreement with the European Investment Bank (EIB). The financing will advance Prodrive Technologies’ R&D initiatives regarding electronic products in the semiconductor, medical, energy and automotive sectors.

In light of Eindhoven’s “route towards climate neutrality”, the municipality has signed an advisory agreement with the European Investment Bank, funded by the European Commission. The city strives to be a healthy, liveable and future-proof place for its citizens, aiming to be fully circular by 2050. As part of this wider strategy, the city wants to use only sustainably generated energy as of 2045, which requires a transition from the current status quo. To break away from fossil fuels, notably natural gas, Eindhoven plans to develop a centralised district heating network and integrate suitable heat sources.